HIV− | HIV+ | P | HIV− >60 years | |
---|---|---|---|---|
Total N | 1417 | 308 | – | 1611 |
N (%) | N (%) | N (%) | ||
Patient characteristics | ||||
Age (years)a | ||||
Median (IQR) | 51(46–56) | 47(40–53) | <0.001 | 72(66–79) |
<40 | 98 (6.9 %) | 80 (25.9 %) | <0.001 | |
41–50 | 567 (40.0 %) | 119 (38.5 %) | ||
51–60 | 752(53.0 %) | 110 (35.6 %) | ||
60–70 | 711 (44.2 %) | |||
>70 | 900 (55.9 %) | |||
Genderb | ||||
Male | 432 (30.6 %) | 293 (95.1 %) | <0.001 | 649 (44.1 %) |
Female | 981 (69.4 %) | 15 (4.9 %) | 956 (55.9 %) | |
Racec | ||||
White | 796 (77.9 %) | 160 (60.6 %) | 0.19 | 1020 (84.7 %) |
Black | 125 (12.3 %) | 55 (20.7 %) | 85 (7.0 %) | |
Hispanic | 50 (4.9 %) | 29 (10.8 %) | 63 (5.2 %) | |
Asian | 15 (1.5 %) | ≤10(<4 %) | 11 (0.8 %) | |
Native American | ≤10 (<1 %) | 0 | 0 | |
Other | 30 (2.9 %) | 16 (6.0 %) | 26 (2.1 %) | |
Comorbidities | ||||
Diabetes | 144 (10.1 %) | 25 (8.2 %) | 0.64 | 223 (13.8 %) |
Cardiovascular | 9 (0.6 %) | 0 | 0.51 | 134 (8.3 %) |
Liver | 19 (1.3 %) | ≤10 (3 %) | 0.85 | 16 (1 %) |
Pulmonary | 180 (12.7 %) | 30 (9.7 %) | 0.49 | 299 (18.6 %) |
Renal | 20 (1.4 %) | ≤10 (3 %) | 0.95 | 43 (2.6 %) |
AIDS | N/A | ≤10 (3 %) | N/A | |
No comorbidity | 1089 (76.8 %) | 252 (81.8 %) | 1055 (62.4 %) | |
Any 1 comorbidity | 286 (20.2 %) | 47 (15.2 %) | 508 (31.6 %) | |
Any 2 comorbidities | 43 (3.0 %) | 9 (2.9 %) | 88 (5.5 %) | |
Any 3 comorbidities | 0 | 0 | ≤10 (0.6 %) | |
≥1 comorbidity | 329 (23.2 %) | 56 (18.1 %) | 0.65 | 606 (37.6 %) |
Perineal tissue flaps | ||||
With | 191 (13.5 %) | 49 (16.0 %) | 0.58 | 113 (7.0 %) |
Without | 1226 (86.5 %) | 259 (84.0 %) | 1497 (93.0 %) | |
Hospital type | ||||
Teaching statusb | ||||
Teaching hospital | 1067 (75.8 %) | 239 (77.4 %) | 929 (57.9 %) | |
Non-teaching hospital | 340 (24.2 %) | 70 (22.7 %) | 0.80 | 676 (42.1 %) |
Hospital locationb | ||||
Urban | 1321 (93.8 %) | 302 (98.1 %) | 0.22 | 1469 (91.5 %) |
Rural | 87 (6.2 %) | ≤10 (<3 %) | 136 (8.48 %) |